Trial intelligence / Profile preview

Topical caffeine 0.3% versus topical minoxidil 5% for androgenetic alopecia

TCTR20261028002Phase 2Completed

Sponsor
Mae Fah Luang University
Start
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of caffeine, minoxidil in androgenetic alopecia (AGA), sponsored by Mae Fah Luang University. Started Feb 2026; status: completed.

02

Drugs

caffeineminoxidil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on TCTR20261028002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20261028002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call